vs

Side-by-side financial comparison of DHT Holdings, Inc. (DHT) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $107.3M, roughly 1.8× DHT Holdings, Inc.). DHT Holdings, Inc. runs the higher net margin — 41.7% vs 6.7%, a 35.0% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -24.5%).

DHT Holdings, Inc. is an independent international crude oil tanker operator that owns and manages a fleet of very large crude carriers. It offers marine transportation services for crude oil across major global trade routes, serving clients including leading oil producers, refineries, and commodity trading enterprises worldwide.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

DHT vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$107.3M
DHT
Growing faster (revenue YoY)
RGEN
RGEN
+38.1% gap
RGEN
13.6%
-24.5%
DHT
Higher net margin
DHT
DHT
35.0% more per $
DHT
41.7%
6.7%
RGEN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DHT
DHT
RGEN
RGEN
Revenue
$107.3M
$197.9M
Net Profit
$44.8M
$13.3M
Gross Margin
52.5%
Operating Margin
44.2%
9.0%
Net Margin
41.7%
6.7%
Revenue YoY
-24.5%
13.6%
Net Profit YoY
27.3%
143.9%
EPS (diluted)
$0.28
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHT
DHT
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$107.3M
$188.8M
Q2 25
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$142.1M
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
DHT
DHT
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$44.8M
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$35.2M
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
DHT
DHT
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
DHT
DHT
RGEN
RGEN
Q4 25
9.0%
Q3 25
44.2%
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
29.7%
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
DHT
DHT
RGEN
RGEN
Q4 25
6.7%
Q3 25
41.7%
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
24.8%
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
DHT
DHT
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.28
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$0.22
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHT
DHT
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$81.3M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.1B
$2.1B
Total Assets
$1.4B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHT
DHT
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$81.3M
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$73.8M
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
DHT
DHT
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHT
DHT
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$1.1B
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$1.0B
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
DHT
DHT
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$1.4B
$2.9B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$1.5B
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
DHT
DHT
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHT
DHT
RGEN
RGEN
Operating Cash FlowLast quarter
$60.9M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.36×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHT
DHT
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$60.9M
$48.1M
Q2 25
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$80.1M
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
DHT
DHT
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
DHT
DHT
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
DHT
DHT
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
DHT
DHT
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.36×
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
2.28×
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons